Autobio Diagnostics Co., Ltd. (SHA:603658)

Autobio Diagnostics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	22,188	24,967	33,123	36,261	32,280	65,473
Market Cap Growth	0.74%	-24.62%	-8.65%	12.33%	-50.70%	61.74%
Enterprise Value	18,926	24,799	33,507	35,789	31,993	65,660
Last Close Price	38.83	42.24	54.05	57.77	50.63	101.96
PE Ratio	19.41	20.90	27.21	31.06	33.15	87.56
Forward PE	17.95	16.30	24.79	28.63	31.67	59.26
PS Ratio	5.13	5.58	7.45	8.16	8.57	21.99
PB Ratio	2.59	2.87	3.82	4.58	4.36	9.94
P/TBV Ratio	2.72	3.00	4.04	4.89	4.69	10.80
P/FCF Ratio	36.03	38.72	58.17	58.48	81.64	-
P/OCF Ratio	18.13	19.07	22.54	23.27	22.09	65.82
EV/Sales Ratio	4.38	5.55	7.54	8.06	8.49	22.05
EV/EBITDA Ratio	12.36	15.34	20.40	23.18	23.87	60.68
EV/EBIT Ratio	17.99	21.52	27.78	31.78	33.53	84.13
EV/FCF Ratio	30.73	38.46	58.84	57.71	80.91	-
Debt / Equity Ratio	0.02	0.06	0.08	0.02	0.04	0.03
Debt / EBITDA Ratio	0.09	0.34	0.44	0.09	0.19	0.19
Debt / FCF Ratio	0.23	0.86	1.28	0.23	0.65	-
Asset Turnover	0.38	0.38	0.40	0.45	0.43	0.48
Inventory Turnover	1.58	1.64	2.11	2.75	2.90	2.97
Quick Ratio	1.89	2.00	2.31	2.49	3.30	3.59
Current Ratio	2.34	2.46	2.66	2.89	3.81	4.05
Return on Equity (ROE)	13.60%	13.82%	14.77%	15.52%	14.01%	16.42%
Return on Assets (ROA)	5.80%	6.15%	6.85%	7.14%	6.87%	7.87%
Return on Capital (ROIC)	7.46%	7.73%	8.64%	8.96%	8.25%	9.49%
Return on Capital Employed (ROCE)	11.50%	12.50%	13.30%	13.60%	12.30%	11.30%
Earnings Yield	5.16%	4.78%	3.67%	3.22%	3.02%	1.14%
FCF Yield	2.78%	2.58%	1.72%	1.71%	1.23%	-0.18%
Dividend Yield	3.24%	2.98%	1.95%	1.39%	1.48%	0.64%
Payout Ratio	63.89%	52.19%	39.36%	37.60%	40.55%	52.61%
Buyback Yield / Dilution	0.14%	0.47%	0.68%	0.48%	-5.10%	-2.03%
Total Shareholder Return	3.38%	3.45%	2.63%	1.87%	-3.62%	-1.39%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.